{
  "paper": {
    "doi": null,
    "pmcid": "PMC_ID_NOT_PROVIDED",
    "title": "Integrating homologous recombination deficiency subtyping with TCGA molecular classification for enhanced prognostic stratification and personalised therapy in endometrial cancer",
    "authors": [
      "Not specified"
    ],
    "journal": "Not specified",
    "year": null,
    "study_type": "retrospective cohort study",
    "eco_type": "clinical study"
  },
  "extraction_provenance": {
    "extraction_pipeline": {
      "name": "medlit_pass1_extract",
      "version": "0.1.0",
      "git_commit": "f5da8dd9b8dd84ea4823af0e58537841df333399",
      "git_commit_short": "f5da8dd",
      "git_branch": "ingest-refactor",
      "git_dirty": true,
      "repo_url": "https://github.com/org/medlit"
    },
    "models": {
      "llm": {
        "name": "claude-sonnet-4-20250514",
        "version": ""
      }
    },
    "prompt": {
      "version": "v1",
      "template": "medlit_extraction_v1",
      "checksum": "sha256:f94cc0ab23940d18"
    },
    "execution": {
      "timestamp": "2026-02-23T22:32:10.332949Z",
      "hostname": "unknown",
      "python_version": "3.13.3",
      "duration_seconds": 53.04
    },
    "entity_resolution": null,
    "model_info": null
  },
  "entities": [
    {
      "id": "disease_1",
      "class": "Disease",
      "name": "endometrial cancer",
      "synonyms": [
        "EC",
        "endometrial carcinoma"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": "C0476089",
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "biomarker_1",
      "class": "Biomarker",
      "name": "homologous recombination deficiency",
      "synonyms": [
        "HRD"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_1",
      "class": "Gene",
      "name": "TP53",
      "synonyms": [
        "tumor protein p53"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:11998",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_2",
      "class": "Gene",
      "name": "POLE",
      "synonyms": [
        "DNA polymerase epsilon"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:9177",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_3",
      "class": "Gene",
      "name": "PTEN",
      "synonyms": [
        "phosphatase and tensin homolog"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:9588",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_4",
      "class": "Gene",
      "name": "BRCA1",
      "synonyms": [
        "BRCA1 DNA repair associated"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:1100",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_5",
      "class": "Gene",
      "name": "BRCA2",
      "synonyms": [
        "BRCA2 DNA repair associated"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:1101",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_6",
      "class": "Gene",
      "name": "ARID1A",
      "synonyms": [
        "AT-rich interaction domain 1A"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:11110",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_7",
      "class": "Gene",
      "name": "RAD51",
      "synonyms": [
        "RAD51 recombinase"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:9817",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_8",
      "class": "Gene",
      "name": "SPOP",
      "synonyms": [
        "speckle type BTB/POZ protein"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:11254",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_9",
      "class": "Gene",
      "name": "PIK3R1",
      "synonyms": [
        "phosphoinositide-3-kinase regulatory subunit 1"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:8979",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_10",
      "class": "Gene",
      "name": "CTNNB1",
      "synonyms": [
        "catenin beta 1"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:2514",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "gene_11",
      "class": "Gene",
      "name": "CTCF",
      "synonyms": [
        "CCCTC-binding factor"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": "HGNC:13723",
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "protein_1",
      "class": "Protein",
      "name": "CD8",
      "synonyms": [
        "cluster of differentiation 8"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "protein_2",
      "class": "Protein",
      "name": "PD-1",
      "synonyms": [
        "programmed cell death protein 1",
        "PDCD1"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "protein_3",
      "class": "Protein",
      "name": "PD-L1",
      "synonyms": [
        "programmed death-ligand 1"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "protein_4",
      "class": "Protein",
      "name": "CD3",
      "synonyms": [
        "cluster of differentiation 3"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "drug_1",
      "class": "Drug",
      "name": "PARP inhibitors",
      "synonyms": [
        "poly(ADP-ribose) polymerase inhibitors"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "drug_2",
      "class": "Drug",
      "name": "platinum-based chemotherapy",
      "synonyms": [
        "platinum compounds"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "drug_3",
      "class": "Drug",
      "name": "immune checkpoint inhibitors",
      "synonyms": [
        "ICIs"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "classification_1",
      "class": "Classification",
      "name": "TCGA molecular classification",
      "synonyms": [
        "The Cancer Genome Atlas classification"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "subtype_1",
      "class": "Subtype",
      "name": "HRD-High",
      "synonyms": [
        "homologous recombination deficiency high"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "subtype_2",
      "class": "Subtype",
      "name": "HRD-Middle",
      "synonyms": [
        "homologous recombination deficiency middle"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "subtype_3",
      "class": "Subtype",
      "name": "HRD-Low",
      "synonyms": [
        "homologous recombination deficiency low"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "subtype_4",
      "class": "Subtype",
      "name": "MSI-H",
      "synonyms": [
        "microsatellite instability-high"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "subtype_5",
      "class": "Subtype",
      "name": "TP53-mutant",
      "synonyms": [
        "TP53 mutant"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "subtype_6",
      "class": "Subtype",
      "name": "TP53-wildtype",
      "synonyms": [
        "TP53 wild-type"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "subtype_7",
      "class": "Subtype",
      "name": "POLE-mutant",
      "synonyms": [
        "POLE mutant"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "outcome_1",
      "class": "Outcome",
      "name": "disease-free survival",
      "synonyms": [
        "DFS"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "outcome_2",
      "class": "Outcome",
      "name": "overall survival",
      "synonyms": [
        "OS"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "outcome_3",
      "class": "Outcome",
      "name": "recurrence",
      "synonyms": [
        "tumor recurrence"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "biomarker_2",
      "class": "Biomarker",
      "name": "HRD score",
      "synonyms": [
        "homologous recombination deficiency score"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "biomarker_3",
      "class": "Biomarker",
      "name": "loss of heterozygosity",
      "synonyms": [
        "LOH"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "biomarker_4",
      "class": "Biomarker",
      "name": "telomeric allelic imbalance",
      "synonyms": [
        "TAI"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    },
    {
      "id": "biomarker_5",
      "class": "Biomarker",
      "name": "large-scale state transitions",
      "synonyms": [
        "LST"
      ],
      "symbol": null,
      "brand_names": [],
      "source": "extracted",
      "canonical_id": null,
      "umls_id": null,
      "hgnc_id": null,
      "rxnorm_id": null,
      "loinc_code": null,
      "uniprot_id": null
    }
  ],
  "evidence_entities": [
    {
      "id": "paper_1:results:1:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "results_1",
      "text": "HRD-High tumours were associated with advanced FIGO stages, TP53 mutations, higher chromosomal instability, and elevated CD8\u207aPD-1\u207a T-cell infiltration",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "retrospective cohort study",
      "eco_type": "clinical study",
      "source": "extracted"
    },
    {
      "id": "paper_1:results:2:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "results_2",
      "text": "HRD subtyping independently predicted disease-free survival and showed superior prognostic accuracy (C-index = 0.857) compared to TCGA subtyping (C-index = 0.751)",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "retrospective cohort study",
      "eco_type": "clinical study",
      "source": "extracted"
    },
    {
      "id": "paper_1:results:3:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "results_3",
      "text": "Integrating HRD and TCGA classifiers further improved predictive performance (C-index = 0.903)",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "retrospective cohort study",
      "eco_type": "clinical study",
      "source": "extracted"
    },
    {
      "id": "paper_1:results:4:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "results_4",
      "text": "An SVM model incorporating HRD score and immune features achieved an AUC of 0.733 for recurrence prediction",
      "confidence": 0.9,
      "extraction_method": "llm",
      "study_type": "retrospective cohort study",
      "eco_type": "clinical study",
      "source": "extracted"
    },
    {
      "id": "paper_1:results:5:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "results_5",
      "text": "HRD-high group was associated with significantly improved outcomes in both DFS (HR = 0.08, 95% CI: 0.03\u20130.21, p = 1.73 \u00d7 10\u22127) and OS (HR = 0.08, 95% CI: 0.02\u20130.28, p = 7.73 \u00d7 10\u22125)",
      "confidence": 0.95,
      "extraction_method": "llm",
      "study_type": "retrospective cohort study",
      "eco_type": "clinical study",
      "source": "extracted"
    },
    {
      "id": "paper_1:results:6:llm",
      "class": "Evidence",
      "entity_id": null,
      "paper_id": "paper_1",
      "text_span_id": "results_6",
      "text": "HRD-high group exhibited higher mutation frequencies in TP53, RAD51, and SPOP, but fewer mutations in PTEN, ARID1A, PIK3R1, CTNNB1, and CTCF",
      "confidence": 0.9,
      "extraction_method": "llm",
      "study_type": "retrospective cohort study",
      "eco_type": "clinical study",
      "source": "extracted"
    }
  ],
  "relationships": [
    {
      "subject": "subtype_1",
      "predicate": "ASSOCIATED_WITH",
      "object": "gene_1",
      "evidence_ids": [
        "paper_1:results:1:llm",
        "paper_1:results:6:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {
        "mutation_frequency": "higher"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "subtype_1",
      "predicate": "ASSOCIATED_WITH",
      "object": "protein_1",
      "evidence_ids": [
        "paper_1:results:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {
        "infiltration": "elevated CD8\u207aPD-1\u207a T-cell"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "biomarker_1",
      "predicate": "INDICATES",
      "object": "outcome_1",
      "evidence_ids": [
        "paper_1:results:2:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.95,
      "properties": {
        "c_index": "0.857"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "biomarker_1",
      "predicate": "INDICATES",
      "object": "outcome_3",
      "evidence_ids": [
        "paper_1:results:4:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.9,
      "properties": {
        "auc": "0.733"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "drug_1",
      "predicate": "TREATS",
      "object": "disease_1",
      "evidence_ids": [
        "paper_1:results:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.85,
      "properties": {
        "context": "HRD-positive tumors"
      },
      "section": "background",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "drug_3",
      "predicate": "TREATS",
      "object": "disease_1",
      "evidence_ids": [
        "paper_1:results:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.85,
      "properties": {
        "context": "immune checkpoint therapy"
      },
      "section": "background",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "subtype_1",
      "predicate": "SUBTYPE_OF",
      "object": "biomarker_1",
      "evidence_ids": [
        "paper_1:results:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 1.0,
      "properties": {},
      "section": "methods",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "subtype_2",
      "predicate": "SUBTYPE_OF",
      "object": "biomarker_1",
      "evidence_ids": [
        "paper_1:results:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 1.0,
      "properties": {},
      "section": "methods",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "subtype_3",
      "predicate": "SUBTYPE_OF",
      "object": "biomarker_1",
      "evidence_ids": [
        "paper_1:results:1:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 1.0,
      "properties": {},
      "section": "methods",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "gene_3",
      "predicate": "ASSOCIATED_WITH",
      "object": "gene_1",
      "evidence_ids": [
        "paper_1:results:6:llm"
      ],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 0.9,
      "properties": {
        "relationship": "mutually exclusive"
      },
      "section": "results",
      "asserted_by": "llm",
      "resolution": null,
      "note": null
    },
    {
      "subject": "biomarker_2",
      "predicate": "SAME_AS",
      "object": "biomarker_1",
      "evidence_ids": [],
      "source_papers": [
        "paper_1"
      ],
      "confidence": 1.0,
      "properties": {},
      "section": "methods",
      "asserted_by": "llm",
      "resolution": null,
      "note": "HRD score is the quantitative measure of homologous recombination deficiency"
    }
  ],
  "notes": [
    "This study demonstrates the clinical utility of HRD subtyping as a complementary biomarker to TCGA molecular classification in endometrial cancer",
    "HRD-High tumors show potential responsiveness to both PARP inhibitors and immune checkpoint inhibitors",
    "The integration of HRD scoring with immune profiling supports precision oncology approaches"
  ]
}